NECTA

NSW Early Phase Clinical Trials Alliance (Australia)

[NECTA @NECTANSW]

Just wrapped up a huge day of amazing talk and engaging discussions! Special thanks to all our sponsors, international and interstate guests and everyone who braved the weather to make it today! #drugdev #oncology #collaboration

[NECTA @NECTANSW]

Our latest podcast is now out! Redefining frustration to success, career insights with Neil Fleshner. We hear about his medical career, launching a successful radio-ligand startup company, and advice for others interested in the space! #biofinance #urology https://t.co/MNoWYNMHuS

[NECTA @NECTANSW]

A great morning of fascinating talks from our guest speakers at the annual NECTA Drug Dev Meeting! Looking forward to more action this afternoon👍

[NECTA @NECTANSW]

Looking forward to meeting everyone tomorrow at our annual Drug Development Meeting! Last chance to register and join us for a day exploring the frontiers in clinical development! https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Only 1 week left until our annual Drug Development Meeting! We can't wait to see everyone there and welcome our international guest speakers! If you haven't registered yet, don't forget to get a ticket at: https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Only a few weeks left until our annual Drug Development Meeting! We can't wait to see everyone there and welcome our international guest speakers! If you haven't registered yet, don't forget to get a ticket at: https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Don't forget to register for our Drug Development Meeting 2026! We have a great panel for the day, from global investigators to biotech. Registrations free for academic affiliations and open at the link: https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Don't forget to register for our Drug Development Meeting 2026! We have a great panel for the day, from global investigators to biotech. Registrations free for academic affiliations and open at the link: https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Registrations are now open for our annual Drug Development Meeting 2026! - Join us for an exciting day meeting with experts in early phase oncology from around the globe!
Registration link below:
https://t.co/PHy7id9tqq

[NECTA @NECTANSW]

Join us as we bring the year to a close by chatting with about how ctDNA testing can inform better treatment decisions in the clinic. We hear about the power of ctDNA + tumour informed testing and the latest data supporting it's use in GI + other cancers. https://t.co/PIiQrlCA6s

[NECTA @NECTANSW]

Join us at NECTA and support early phase trials in NSW - we have a great opportunity open for a Regulatory Affairs Officer.
https://t.co/BTSctK6Jf6

[Cancer Institute NSW @cancerNSW]

Congratulations Associate Professor @AbhijitPal, Medical Oncologist at @SouthWesternSydneyLocalHealthDistrict – winner of the 2025 Improving Equitable Outcomes through Cancer Research Award. #CancerNSWAwards

[Cancer Institute NSW @cancerNSW]

Congratulations Associate Professor Inês Esteves Domingues Pires da Silva – 2025 Outstanding Mid Career Researcher of the Year. A/Prof Pires da Silva is a distinguished Medical Oncologist and Associate Professor at the @MelanomaAus and @Sydney_Uni. #CancerNSWAwards

[NECTA @NECTANSW]

We're back after a fascinating talk with Dr Laura Chang at @arteraAI about predictive use of AI in digitalised pathology. Tune in to hear more about how tech is improving prognostic and predictive cancer care outcomes! #AI #cancercare #tech https://t.co/P0e6eMUZdw

[Jia (Jenny) Liu MD PhD @JiaJennyLiu]

Delighted to share 2 posters @myESMO #ESMO25 - poster award for GRWD5769 ERAP1 inhibitor in adv solid tumors, and @NECTANSW PANNA-COTA study matching 🩸 🧬 with early phase trial enrolment

🙏 to participating patients carers and collaborating sites

[Jia (Jenny) Liu MD PhD @JiaJennyLiu]

While potentially practice changing few of these are immediately actionable in the real world 🌏 due to delays in funding, approval and access.

🗺️ regulatory harmonisation needed to bring 🔬💊 from the podium into everyday practice for our patients who waiting 🩺👩‍⚕️💕 #ESMO25

[Guardant Health AMEA @GuardantAMEA]

Looking forward to #ESMO25, where clinicians will share results from research collaborations with Guardant Health AMEA, and new real-world data across solid tumor types.

A heartfelt thank you to the researchers and collaborators @JiaJennyLiu, @docrohatgi Nir Peled, Amit Rauthan, Shota Fukuoka, @kobashin0117, @Hiroki_Osumi, and Seiichiro Mitani.

We remain committed to collaborating with clinicians to advance real-world evidence in precision oncology.

[NECTA @NECTANSW]

Excited to announce our Drug Development Meeting will be returning next 27 March. Save the date!

[Cancer Institute NSW @cancerNSW]

Great to see the work of NECTA on early phase clinical trials - presented by Dr Rasha Cosman, @GarvanInstitute. The Cancer Institute NSW is proud to support this incredible work across the state. #NSWCancerSummit2025

[NECTA @NECTANSW]

The NECTA team will be attending ASCO 2025 in Chicago and welcome meetings to talk about phase 1 trials in Australia. Feel free to reach out! #NECTANSW #drugdevelopment #phase1